The Dual Agonist: Tirzepatide Tirzepatide targets two distinct nutrient-stimulated hormone pathways: GLP-1 (Glucagon-Like Peptide-1): Activates receptors in the brain to delay gastric emptying, induce early satiety, and reduce central appetite signals
They reduce hunger, slow digestion, and support calorie control
Now its being squeezed into a $50 window
But you should reach out to your prescribing physician if you experience any of the following: Symptoms that are severe or worsening after two weeks at the same dose Signs of dehydration such as dark urine, dizziness, dry mouth, or rapid heart rate Blood in your stool or severe abdominal cramping Inability to keep food or fluids down Fever accompanying your symptoms Your provider can slow your dose escalation schedule, temporarily reduce your dose, or recommend supportive medications
The good news: Experts say millions more of us also stand to benefit
Mechanism of Action: When semaglutide binds to GLP-1 receptors, it stimulates the production of insulin while inhibiting the release of glucagon
